NFKB1 and atherosclerosis: ZAP70/NF-κB inhibitors may be a potential therapeutic target for the treatment of P. gingivalis-mediated Th1 cell-related diseases, such as EAE, angiotensin II-dependent hypertension, and atherosclerosis.